HS

Howard Scher

Senior Advisor at Arsenal Capital Partners

Dr. Scher is a Senior Advisor for the healthcare team. He currently serves as the Head of the Biomarker Development Program and is the D. Wayne Calloway Chair in Urologic Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Scher has served as a Professor of Medicine at Weill Cornell Medical College since 2000. He joined Memorial Sloan-Kettering in 1992 as the Chief of Genitourinary Oncology Service. Previously, he was a Principle Investigator for the Department of Defense prostate cancer research program and a Researcher for the Prostate Cancer Foundation.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Arsenal Capital Partners

3 followers

Arsenal is a leading private equity firm that specializes in investments in middle-market specialty industrials and healthcare companies.


Employees

51-200

Links